HyBryte™ FLASH Study Selected as a ‘Top Poster’ Winner for Presentation at the National Organization for Rare Disorders’ Rare Diseases and Orphan Products Breakthrough Summit
PRINCETON, N.J., Oct. 12, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Firm), a late-stage biopharmaceutical firm centered ...
